Sign in

CIK 0001069899

  • Large accelerated filer

PHIBRO ANIMAL HEALTH CORP

Sign in to watch
Ticker
PAHC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
131840497
Phone
+1 201-329-7300
Business address
GLENPOINTE CENTRE EAST, 3RD FLOOR, 300 FRANK W. BURR BLVD., SUITE 21, TEANECK, NJ, 07666
Former names
PHILIPP BROTHERS CHEMICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-08-06 David Glenn Chief Financial Officer Grant or award +3,482 54,959
2026-08-06 David Glenn Chief Financial Officer Grant or award +3,334 54,811
2026-08-04 David Glenn Chief Financial Officer Other disposition −840 $36.60 $31K 51,477
2026-02-11 David Glenn Chief Financial Officer Other disposition −12,528 $51.63 $647K 52,317
2026-02-09 David Glenn Chief Financial Officer Exercise or conversion +30,000 64,845
2026-02-09 David Glenn Chief Financial Officer Exercise or conversion · Restricted Stock Units −30,000 240,000
2025-08-15 David Glenn Chief Financial Officer Grant or award +4,845 34,845
2025-02-09 David Glenn Chief Financial Officer Exercise or conversion +30,000 30,000
2025-02-09 David Glenn Chief Financial Officer Exercise or conversion · Restricted Stock Units −30,000 270,000
2024-02-09 David Glenn Chief Financial Officer Grant or award · Restricted Stock Units +300,000 300,000

Page 1 of 1 · 10 trades